CME Instructions - April 2015

CME Reviews: Volume 31, No. 2

Release date: May 19, 2015

Expiration date: May 19, 2016

Media used: Internet-based

Estimated time to complete this CME activity: 1 hour

Statement of Need

Cardiovascular disease (CVD) is the leading cause of death in the United States. It is estimated that 83 million American adults have 1 or more forms of CVD. New agents, procedures, and interventions have improved patient outcomes, with decreased mortality and morbidity rates. However, as the population ages and younger adults develop comorbidities due to unhealthy lifestyles, the patient population at risk for cardiovascular events is increasing.

Care for patients with CVD has become increasingly complex, and community-based cardiologists often struggle to stay up-to-date with the volume of new data. The overall goals of this publication are to provide timely and pertinent original research articles that review current guidelines, practices, and new developments in the field of cardiovascular medicine. The publication also emphasizes preventing CVD by modifying risk factors through such strategies as healthy eating, regular exercise, and avoidance of smoking.

Target Audience

The target audience for this activity is cardiologists.

CME Learning Objectives

At the conclusion of this activity, participants should be able to:

1. Gain insight into the efficacy of the coronary sinus reducer in patients with refractory angina.

2. Compare the role of fractional flow reserve by coronary angiography versus atherosclerotic plaque characteristics by coronary CT angiography for prognosis.

Financial Disclosure

As a sponsor accredited by the ACCME, it is the policy of Physicians’ Education Resource®, LLC (PER®), to require the disclosure of anyone who is in a position to control the content of an educational activity. All relevant financial relationships with any commercial interests and/or manufacturers must be disclosed to participants prior to the beginning of each CME activity. PER has identified and resolved all conflicts of interest prior to the release of this activity.

Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.

Sources of Funding

No educational grants from commercial interests were received.

Instructions for Receiving Credit

In order to receive a CME certificate for this activity, participants must read each review and activity in its entirety.

In order to receive a CME certificate, participants should:

• Go to this link: http://www.gotoper.com/link/172
• Click on “Request CME Credit” button on yellow box, login and take posttest.
• Participants must complete the posttest and pass with a score of 70% or higher, complete the evaluation, and request for credit. Participants may immediately download a CME certificate upon completion of these steps.

Accreditation and Designation of Credit

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Editor in Chief:

Debabrata Mukherjee, MD, MS, FACC

Chief, Cardiovascular Medicine

Clinical and Research Fellow

Vice Chairman, Department of Internal Medicine

Texas Tech University Health Sciences Center

El Paso, TX

Alison L. Bailey, MD

Assistant Professor of Medicine

Director, Cardiac Rehabilitation

Associate Director, Cardiovascular Fellowship Program

Gill Heart Institute

University of Kentucky

Lexington, KY

Leslie Campbell, MD, FACC

Director, Advanced Heart Failure and Transplant

Barry S. Levin, M.D. Department of Transplantation

California Pacific Medical Center

San Francisco, CA

Saurav Chatterjee, MD

Fellow, Cardiovascular Diseases

Division of Cardiology

St. Luke’s-Roosevelt Hospital Center

New York, NY

Nezar Falluji, MD, MPH, FACC, FSCAI

Interventional Cardiologist

Executive Director, Kentucky One Health Cardiovascular Service Line

Co-director, Trans-catheter Valve Program

Saint Joseph Heart and Vascular Institute

Lexington, KY

Maryna Popp Switzer, DO

Texas Tech University Health Sciences Center

El Paso, TX

The following individuals have no relevant financial relationships with commercial interests to disclose:

Authors: Sucheta Gosavi, MD; Niki Katsiki, MsC, PhD, MD, FRsPh; Harold L. Lazar, MD; Glenn N. Levine, MD, FACC, FAHA; Rabab Mohsin, MD; Karla Quevedo, MD; Khaled M. Ziada, MD, FACC, FSCAI

Planner, reviewer, and editor in chief: Debabrata Mukherjee, MD, MS, FACC

Planner, reviewer, and editor-in-chief: Debabrata Mukherjee, MD, MS, FACC

PER® planners and staff: Ann C. Lichti, CHCP; Emily Valko Lohrmann; and Kerry Clayton

Cardiology Review staff: Todd Kunkler; Jackie Syrop

Provider Contact Information:

Physicians’ Education Resource®, LLC

666 Plainsboro Road, Suite 356

Plainsboro, NJ 08536

Toll Free: 888-949-0045

Local: 609-378-3701

Fax: 609-257-0705

info@gotoper.com